Paliperidone palmitate may reduce schizophrenia treatment failure in Black patients
Paliperidone palmitate appeared to benefit Black patients with recent-onset schizophrenia or schizophreniform disorder, according to study results presented at NEI Congress.
Opioid dispensing declines for patients with schizophrenia, bipolar disorder
Prescription opioid dispensing decreased for patients with schizophrenia, as well as those with bipolar disorder, between 2015 and 2019, according to study results presented at NEI Congress.
Health worse in patients concerned about developing drug-induced movement disorders
Patients from community mental health centers who expressed concerns about developing drug-induced movement disorders tended to report worse health and daily functioning, according to study results presented at NEI Congress.
Latuda may improve life satisfaction, social relationships in bipolar depression
Latuda use was associated with statistically significant improvements on individual quality-of-life items compared with placebo among patients with bipolar depression.